These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1345742)

  • 1. On the role of interleukin-2 (IL-2) in multiple sclerosis (MS). IL-2-mediated endothelial cell activation.
    Gallo P; Pagni S; Piccinno MG; Giometto B; Argentiero V; Chiusole M; Bozza F; Tavolato B
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):65-8. PubMed ID: 1345742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial activation during interleukin 2 immunotherapy. A possible mechanism for the vascular leak syndrome.
    Cotran RS; Pober JS; Gimbrone MA; Springer TA; Wiebke EA; Gaspari AA; Rosenberg SA; Lotze MT
    J Immunol; 1988 Mar; 140(6):1883-8. PubMed ID: 3279124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone].
    Yagi Y; Takahashi M; Nakamura Y
    Rinsho Shinkeigaku; 1997 Jul; 37(7):575-9. PubMed ID: 9396353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha.
    Claudio L; Martiney JA; Brosnan CF
    Lab Invest; 1994 Jun; 70(6):850-61. PubMed ID: 8015289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell lymphokine-induced secretion of cytokines by monocytes from patients with multiple sclerosis.
    Maimone D; Reder AT; Gregory S
    Cell Immunol; 1993 Jan; 146(1):96-106. PubMed ID: 8425234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile of myelin basic protein-reactive T cells in multiple sclerosis and healthy individuals.
    Hermans G; Stinissen P; Hauben L; Van den Berg-Loonen E; Raus J; Zhang J
    Ann Neurol; 1997 Jul; 42(1):18-27. PubMed ID: 9225681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to and production of interleukin 2 by peripheral blood and cerebrospinal fluid lymphocytes of patients with multiple sclerosis.
    Merrill JE; Mohlstrom C; Uittenbogaart C; Kermaniarab V; Ellison GW; Myers LW
    J Immunol; 1984 Oct; 133(4):1931-7. PubMed ID: 6088630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10-modulated immature dendritic cells control the proinflammatory environment in multiple sclerosis.
    Adikari SB; Pettersson A; Soderstrom M; Huang YM; Link H
    Scand J Immunol; 2004 Jun; 59(6):600-6. PubMed ID: 15182256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adhesion molecule and cytokine profile of multiple sclerosis lesions.
    Cannella B; Raine CS
    Ann Neurol; 1995 Apr; 37(4):424-35. PubMed ID: 7536402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-2 levels in serum and cerebrospinal fluid of multiple sclerosis patients.
    Gallo P; Piccinno M; Pagni S; Tavolato B
    Ann Neurol; 1988 Dec; 24(6):795-7. PubMed ID: 3264690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution of interleukin-2 receptor bearing lymphocytes in multiple sclerosis: evidence for a key role of activated lymphocytes.
    Bellamy AS; Calder VL; Feldmann M; Davison AN
    Clin Exp Immunol; 1985 Aug; 61(2):248-56. PubMed ID: 3930109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Blood-brain barrier in multiple sclerosis: mechanisms of its breakdown and repair].
    Kanda T
    Nihon Rinsho; 2003 Aug; 61(8):1402-8. PubMed ID: 12962030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated endothelial cells resist lymphokine-activated killer cell-mediated injury. Possible role of induced cytokines in limiting capillary leak during IL-2 therapy.
    Mier JW; Brandon EP; Libby P; Janicka MW; Aronson FR
    J Immunol; 1989 Oct; 143(7):2407-14. PubMed ID: 2528594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Th1/Th2 cytokine balance and nitric oxide in cerebrospinal fluid and serum from patients with multiple sclerosis.
    Rodríguez-Sáinz Mdel C; Sánchez-Ramón S; de Andrés C; Rodríguez-Mahou M; Muñoz-Fernández MA
    Eur Cytokine Netw; 2002; 13(1):110-4. PubMed ID: 11956029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the immunomodulatory effects of the plant sterol beta-sitosterol to simvastatin in peripheral blood cells from multiple sclerosis patients.
    Desai F; Ramanathan M; Fink CS; Wilding GE; Weinstock-Guttman B; Awad AB
    Int Immunopharmacol; 2009 Jan; 9(1):153-7. PubMed ID: 19022404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma and interleukin-4-producing T cells in peripheral blood of multiple sclerosis patients.
    Franciotta D; Zardini E; Bergamaschi R; Andreoni L; Cosi V
    Eur Cytokine Netw; 2000 Dec; 11(4):677-81. PubMed ID: 11125313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.